Old Web
English
Sign In
Acemap
>
authorDetail
>
Steve Greenberg
Steve Greenberg
Novartis
Immunology
Medicine
Asthma
in patient
Omalizumab
3
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
2017
Journal of Dermatological Science
Michihiro Hide
Hae-Sim Park
Atsuyuki Igarashi
Young-Min Ye
Tae-Bum Kim
Akiko Yagami
Joo Young Roh
Jae Hyun Lee
Yuko Chinuki
Sang Woong Youn
Soo-Keol Lee
Naoko Inomata
Jeong Hee Choi
Atsushi Fukunaga
Junyi Wang
Soichiro Matsushima
Steve Greenberg
Sam Khalil
Show All
Source
Cite
Save
Citations (26)
Blood Eosinophils and Serum IgE Predict Response to Omalizumab in Patients with Severe Allergic Asthma: Innovate Trial Post-Hoc Analysis
2016
The Journal of Allergy and Clinical Immunology
Volkan Manga
Marc Humbert
Ratko Djukanovic
Steve Greenberg
Theodore A. Omachi
Benjamin Trzaskoma
Roland Buhl
Show All
Source
Cite
Save
Citations (9)
Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the Tenor II Cohort
2016
The Journal of Allergy and Clinical Immunology
Larry Borish
Stanley J. Szefler
Robert S. Zeiger
Aimee J. Foreman
Steve Greenberg
Tmirah Haselkorn
Farid Kianifard
Meryl Mendelson
Brandee Paknis
Scott T. Weiss
Bradley E. Chipps
Show All
Source
Cite
Save
Citations (0)
1